Showing 3261-3270 of 9401 results for "".
Understanding the Structure, Function, and Strategies for Repair of the Epidermal Barrier
https://practicaldermatology.com/topics/general-topics/PD0509_08-php/22830/Recent research has improved our understanding of barrier function and opened new therapeutic avenues.From Clinician to Investigator: Staying Ethical in Industry-Sponsored Trials
https://practicaldermatology.com/topics/practice-management/from-clinician-to-investigator-staying-ethical-in-industry-sponsored-trials/23978/Rising Skin Cancer Rates are a Global Reality
https://practicaldermatology.com/topics/general-topics/PD1009_04-php/20367/One group of researchers questions the skin cancer epidemic, but the overwhelming evidence suggests that rates are rising.Case Report: First Reported Case of Facial Rash After Dupilumab Therapy; Call for Abstracts
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-first-reported-case-of-facial-rash-after-dupilumab-therapy-call-for-abstracts/20499/Common SEO Mistakes Could Dilute Your Dermatology Content Marketing Results
https://practicaldermatology.com/topics/practice-management/common-seo-mistakes-could-dilute-your-dermatology-content-marketing-results/20793/Spot common but avoidable mistakes that hurt your SEO rankings.Systemic Corticosteroids, Chronic Inflammatory Skin Disease, and COVID-19: What Do We Know?
https://practicaldermatology.com/topics/infections-infectious-disease/systemic-corticosteroids-chronic-inflammatory-skin-disease-and-covid-19-what-do-we-know/23615/An assessment of the risk of COVID-19 infection imposed by systemic corticosteroid use in the setting of chronic inflammatory skin disease.First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.Dermatology Q&A: First Head-to-Head Data Highlight Safety and Efficacy of Biologics
https://practicaldermatology.com/topics/psoriasis/first-head-to-head-data-highlight-safety-and-efficacy-of-biologics/22032/A lead investigator on the first head-to-head trial of biologics shares insights on the future of biologic research and therapy.Diagnosing and Managing Hair Disorders
https://practicaldermatology.com/topics/general-topics/diagnosing-and-managing-hair-disorders/20624/From loss to overgrowth, hair disorders may be associated with systemic causes.Rebooting the C. acnes Narrative
https://practicaldermatology.com/topics/acne-rosacea/rebooting-the-ic-acnesi-narrative/23623/